Quality Assurance

John Lowton
Director, Quality Assurance and Regulatory Affairs

John Lowton has over 20 years of experience in various Quality Assurance roles. Over the last 6 years, John worked at Genzyme where he was responsible for Quality Assurance of the commercial manufacturing of Cerezyme®. Prior to that John worked at Goodwin in 2011 in the QA department after having worked at VTS Products and SNS Pharmaceuticals as a Quality Assurance Manager for the previous 12 years. John earned a Bachelor’s degree in Applied and Industrial Biology at South Bank University in London.

Sandra Isaacs, CQA
Senior Manager, QA – Product Release

Sandra has nearly 20 years of experience in developing and optimizing Quality Systems in cGMP environments for manufacturing biopharmaceuticals, pharmaceuticals, medical devices, as well as human cells / tissue and tissue-based products. Prior to joining Goodwin Biotechnology nearly 7 years ago, she managed the QA department at Bio-Tissue Inc. and worked as a Quality Management Systems Specialist at Andrx Pharmaceuticals. Sandra earned her Bachelor of Science degree in Chemistry, Physics, and Biochemistry at the University of the West Indies and has completed post graduate studies to earn a graduate certificate in Total Quality Management from the College of Engineering at the University of South Florida. Sandra has also earned a Certified Quality Auditor certification from the American Society for Quality (ASQ).

Thomas Sutera
Manager, QA – System Compliance

Thomas has over 3 decades of experience in the Biotechnology, Pharmaceutical, and Consumer Healthcare industries. He is responsible for the QA Systems Compliance department at Goodwin Biotechnology. Prior to joining Goodwin, he started his career in QC testing and formulating media and buffer solutions for manufacturing vaccines at American Cyanamid. He continued to focus on Quality assignments as a training specialist in the QA, QC, Technology, and Manufacturing sections at Wyeth. Thomas then leveraged those experiences to become a Senior QA Associate and managed the Document Control department at Pfizer’s facility in Pearl River, New York where they manufactured vaccines.

It is the policy of Goodwin Biotechnology to use appropriate management systems to carry out our mission. Quality is the intrinsic focus of all management practices that make up these systems. These practices include the following elements: proper planning, performance of appropriate tasks, timely assessment, and continuous improvement of established processes. By addressing these elements in the research, development, operations, and support activities, defined goals are met and both the Goodwin Biotechnology and the client requirements are satisfied. All work is performed with dedication to excellence and with an objective of dynamic and continuous improvement.

Each department at Goodwin Biotechnology involved in GMP manufacturing maintains a quality program that meets its specific needs and is consistent with the guidelines provided in the Goodwin Biotechnology Quality program. Goodwin Biotechnology Quality Assurance continually monitors these programs to assess their effectiveness. Quality Assurance is also responsible for review, approval, and control of critical processing steps, component release, and documentation in support of GMP manufacturing. Our quality systems include:

cGMP Documentation
Audit and Review
Approval and Release
Vendor Audit
cGMP Training
CAPA

Goodwin Biotechnology has established a Drug Master File (DMF) with the FDA.

Quality Assurance maintains programs for vendor qualification, and internal and external audits, as well as procedures for responding to client and regulatory agency audits of Goodwin Biotechnology operations.

For more information on our Quality Assurance services please fill out the form below.

Support Services Links